Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

136.09 UNCHANGED
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech
NEW YORK — In a dramatic shift that has redefined the market landscape of 2025, small-cap stocks have surged to historic levels, signaling what many analysts are calling the "Great Rotation." On... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025
As of mid-December 2025, the long-awaited "Great Rotation" in the financial markets has shifted from a theoretical prediction to a dominant reality. For the better part of the last three years,... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Earnings Scheduled For October 28, 2025 ↗
 
Via Benzinga
News headline image
GeneDx Hldgs's Earnings: A Preview ↗
 
Via Benzinga
News headline image
GeneDx Holdings Corp. (NASDAQ:WGS) Passes Minervini Trend Template and High-Growth Momentum Screen ↗
GeneDx (WGS) stock passes a strict growth screen, combining Minervini's strong trend template with accelerating earnings and sales fundamentals. 
Via Chartmill
News headline image
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
From GeneDx
Via Business Wire
News headline image
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump ↗
The AI-powered genetic-testing company has been a strong performer. The CEO's recent move had more to do with accounting than conviction. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade ↗
The upgraded 74 RS Rating shows that the Chicago area-based home health care firm tops more than 70% of stocks for price performance. 
Via Investor's Business Daily
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Presents a Strong Case for Growth Momentum and Technical Breakout ↗
GeneDx (WGS) shows explosive earnings growth of 1,125% and strong technicals, presenting a high-growth momentum and breakout opportunity. 
Via Chartmill
News headline image
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
The investment company displayed confidence in Teladoc's growth potential by expanding its holdings in the stock. 
Via The Motley Fool
News headline image
6 Healthcare Stocks With Strong Upward Momentum ↗
 
Via Benzinga
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing ↗
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
From GeneDx
Via Business Wire
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Emerges as a Premier Growth and Momentum Stock ↗
GeneDx (WGS) stock aligns with growth & momentum strategies, showing a powerful uptrend backed by explosive earnings growth and strong technical health. 
Via Chartmill
News headline image
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
News headline image
What Does the Market Think About GeneDx Holdings Corp? ↗
 
Via Benzinga
News headline image
GeneDx (WGS) Q3 2025 Earnings Call Transcript ↗
GeneDx (WGS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher ↗
GeneDx Q3 2025 earnings crush estimates with 52% revenue growth. Strong exome/genome test demand and raised 2025 guidance fuel investor optimism. 
Via Chartmill
Topics Earnings
News headline image
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
News headline image
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
From GeneDx
Via Business Wire
News headline image
4 Analysts Assess GeneDx Holdings: What You Need To Know ↗
 
Via Benzinga
News headline image
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
From GeneDx
Via Business Wire
News headline image
This WillScot Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
From GeneDx
Via Business Wire
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Presents a High-Growth Momentum and Technical Breakout Case ↗
GeneDx stock shows strong growth momentum with 600% EPS growth and a bullish technical setup, signaling a potential breakout for investors. 
Via Chartmill
News headline image
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
From GeneDx
Via Business Wire
News headline image
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
From GeneDx
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.